Mild Hyperbaric Oxygen Therapy (mHBOT)

Mild Hyperbaric Oxygen Therapy (mHBOT) at Ikigai Medical involves breathing concentrated oxygen inside a pressurised chamber at slightly above atmospheric pressure. The elevated pressure — typically 1.3 to 1.5 atmospheres absolute (ATA) in mild HBOT protocols — allows oxygen to dissolve more readily into blood plasma, reaching tissues and cells that oxygen-bound haemoglobin cannot effectively supply under normal conditions. This enhanced oxygen delivery…

The therapy is positioned at Ikigai Medical as a wellness and longevity protocol addressing a range of common health concerns. Clinical research has demonstrated that hyperbaric oxygen exposure can improve sleep quality, including helping with sleep initiation, reducing nighttime awakenings, and enhancing overall sleep architecture. Patients frequently report improvements in mental acuity, cognitive clarity, and sustained energy levels following a course…

From a longevity science perspective, one of the most significant findings relates to the impact of HBOT on cellular ageing markers. Research published in peer-reviewed journals has shown that repeated hyperbaric oxygen sessions can measurably lengthen telomeres — the protective caps on chromosomes that shorten with age and are considered a key biomarker of biological ageing — as well as reduce the burden of senescent cells, which are dysfunctional cells…